论文部分内容阅读
重组促红细胞生成素广泛用于慢性肾功能衰竭贫血患者的治疗已近 1 0年 ,人们发现越来越多的患者对重组促红细胞生成素的治疗有抵抗现象 ,本文就红细胞生成素抵抗的原因及对策进行综述。
Recombinant erythropoietin is widely used in the treatment of anemia patients with chronic renal failure in the past 10 years, more and more patients were found to be resistant to the treatment of recombinant erythropoietin. In this paper, the causes of erythropoietin resistance And measures to review.